Skip to main content
Premium Trial:

Request an Annual Quote

UD Partners with Optive Research for Grid-Based Drug Discovery

NEW YORK, Aug. 4 (GenomeWeb News) - United Devices said today that it is partnering with computer-assisted drug discovery software firm Optive Research to optimize the newly launched company's software for UD's Grid MP distributed computing platform.

 

The Grid MP technology - which harnesses unused computing cycles from clusters, servers, desktops, and workstations into a single computing platform - is now available with Optive's DiverseSolutions software for chemical diversity and library design, UD said.

 

The companies said they are also planning to provide Optive's Confort software for conformational searching and sampling, as well as its EA-Inventor software for de novo molecular design.

 

Further information on the partnership is available here.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.